Merge pull request 'extract: 2025-04-07-tufts-health-affairs-medically-tailored-meals-50-states' (#1204) from extract/2025-04-07-tufts-health-affairs-medically-tailored-meals-50-states into main
Some checks are pending
Sync Graph Data to teleo-app / sync (push) Waiting to run

This commit is contained in:
Leo 2026-03-18 09:24:37 +00:00
commit a0fb81cc21
4 changed files with 52 additions and 1 deletions

View file

@ -23,6 +23,12 @@ The near-term trajectory: mandatory outpatient screening by 2026, Z-code adoptio
The Commonwealth Fund's 2024 international comparison provides quantified evidence of the population-level cost of not operationalizing SDOH interventions at scale. The US ranks second-worst on equity (9th of 10 countries) and last on health outcomes (10th of 10), with the highest healthcare spending (>16% of GDP). This outcome gap relative to peer nations with lower spending demonstrates the opportunity cost of the US healthcare system's failure to systematically address social determinants. Countries with better equity and access outcomes (Australia, Netherlands) achieve superior population health despite similar or lower clinical quality and lower spending ratios. The international comparison quantifies what the SDOH adoption gap costs: the US achieves worst population health outcomes among wealthy peer nations despite world-class clinical care, suggesting that the 3% Z-code documentation rate represents billions in foregone health gains. The Commonwealth Fund's 2024 international comparison provides quantified evidence of the population-level cost of not operationalizing SDOH interventions at scale. The US ranks second-worst on equity (9th of 10 countries) and last on health outcomes (10th of 10), with the highest healthcare spending (>16% of GDP). This outcome gap relative to peer nations with lower spending demonstrates the opportunity cost of the US healthcare system's failure to systematically address social determinants. Countries with better equity and access outcomes (Australia, Netherlands) achieve superior population health despite similar or lower clinical quality and lower spending ratios. The international comparison quantifies what the SDOH adoption gap costs: the US achieves worst population health outcomes among wealthy peer nations despite world-class clinical care, suggesting that the 3% Z-code documentation rate represents billions in foregone health gains.
### Additional Evidence (challenge)
*Source: [[2025-04-07-tufts-health-affairs-medically-tailored-meals-50-states]] | Added: 2026-03-18*
The JAMA Internal Medicine 2024 RCT testing intensive food-as-medicine intervention (10 meals/week + education + coaching for 1 year) found NO significant difference in HbA1c, hospitalization, ED use, or total claims between treatment and control groups. This challenges the assumption that SDOH interventions produce strong ROI—the RCT evidence shows null clinical outcomes despite addressing food insecurity directly.
--- ---
Relevant Notes: Relevant Notes:

View file

@ -47,6 +47,12 @@ The NHS paradox—ranking 3rd overall while having catastrophic specialty access
WHO's three-pillar framework for GLP-1 obesity treatment explicitly positions medication as one component within a comprehensive approach requiring healthy diets, physical activity, professional support, and population-level policies. WHO states obesity is a 'societal challenge requiring multisectoral action — not just individual medical treatment.' This institutional positioning from the global health authority confirms that pharmaceutical intervention alone cannot address health outcomes driven by behavioral and social factors. WHO's three-pillar framework for GLP-1 obesity treatment explicitly positions medication as one component within a comprehensive approach requiring healthy diets, physical activity, professional support, and population-level policies. WHO states obesity is a 'societal challenge requiring multisectoral action — not just individual medical treatment.' This institutional positioning from the global health authority confirms that pharmaceutical intervention alone cannot address health outcomes driven by behavioral and social factors.
### Additional Evidence (extend)
*Source: [[2025-04-07-tufts-health-affairs-medically-tailored-meals-50-states]] | Added: 2026-03-18*
While social determinants predict health outcomes in observational studies, RCT evidence from food-as-medicine interventions shows that directly addressing social determinants (food insecurity) does not automatically improve clinical outcomes. The AHA 2025 systematic review of 14 US RCTs found Food Is Medicine programs improve diet quality and food security but "impact on clinical outcomes was inconsistent and often failed to reach statistical significance." This suggests the causal pathway from social determinants to health is more complex than simple resource provision.
--- ---
Relevant Notes: Relevant Notes:

View file

@ -0,0 +1,26 @@
{
"rejected_claims": [
{
"filename": "food-as-medicine-simulation-models-project-massive-savings-but-rcts-show-null-clinical-outcomes-exposing-causal-inference-gap.md",
"issues": [
"missing_attribution_extractor",
"opsec_internal_deal_terms"
]
}
],
"validation_stats": {
"total": 1,
"kept": 0,
"fixed": 1,
"rejected": 1,
"fixes_applied": [
"food-as-medicine-simulation-models-project-massive-savings-but-rcts-show-null-clinical-outcomes-exposing-causal-inference-gap.md:set_created:2026-03-18"
],
"rejections": [
"food-as-medicine-simulation-models-project-massive-savings-but-rcts-show-null-clinical-outcomes-exposing-causal-inference-gap.md:missing_attribution_extractor",
"food-as-medicine-simulation-models-project-massive-savings-but-rcts-show-null-clinical-outcomes-exposing-causal-inference-gap.md:opsec_internal_deal_terms"
]
},
"model": "anthropic/claude-sonnet-4.5",
"date": "2026-03-18"
}

View file

@ -7,10 +7,14 @@ date: 2025-04-07
domain: health domain: health
secondary_domains: [] secondary_domains: []
format: paper format: paper
status: unprocessed status: enrichment
priority: high priority: high
triage_tag: claim triage_tag: claim
tags: [food-as-medicine, medically-tailored-meals, cost-effectiveness, SDOH, behavioral-health-infrastructure] tags: [food-as-medicine, medically-tailored-meals, cost-effectiveness, SDOH, behavioral-health-infrastructure]
processed_by: vida
processed_date: 2026-03-18
enrichments_applied: ["SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action.md", "medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm.md"]
extraction_model: "anthropic/claude-sonnet-4.5"
--- ---
## Content ## Content
@ -58,3 +62,12 @@ Geisinger Fresh Food Farmacy (pilot, n=37):
## Curator Notes ## Curator Notes
PRIMARY CONNECTION: SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action PRIMARY CONNECTION: SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action
WHY ARCHIVED: The simulation-vs-RCT tension is the most important finding of this session. It challenges the assumption that addressing social determinants automatically improves health — the causal pathway may be more complex than "fix the determinant, fix the outcome." WHY ARCHIVED: The simulation-vs-RCT tension is the most important finding of this session. It challenges the assumption that addressing social determinants automatically improves health — the causal pathway may be more complex than "fix the determinant, fix the outcome."
## Key Facts
- Tufts simulation model projects 10.8M hospitalizations prevented and $111.1B net savings over 5 years from MTM intervention
- Eligible MTM population: 14+ million Americans with average $30,900 annual healthcare expenditure
- Mean MTM program expense: $11.15 per meal (Food is Medicine Coalition 2024 survey)
- JAMA 2024 RCT: intensive food intervention showed HbA1c difference of -0.10 (95% CI -0.46 to 0.25, P=.57) vs control
- Geisinger pilot (n=37): HbA1c dropped from 9.6 to 7.5, healthcare costs dropped 80%
- AHA 2025 review covered 14 US RCTs, found inconsistent clinical outcomes despite improved diet quality